ES2053429T3 - El uso de buspirona para la preparacion de composiciones farmaceuticas para aliviar la ansiedad fobica. - Google Patents
El uso de buspirona para la preparacion de composiciones farmaceuticas para aliviar la ansiedad fobica.Info
- Publication number
- ES2053429T3 ES2053429T3 ES86114795T ES86114795T ES2053429T3 ES 2053429 T3 ES2053429 T3 ES 2053429T3 ES 86114795 T ES86114795 T ES 86114795T ES 86114795 T ES86114795 T ES 86114795T ES 2053429 T3 ES2053429 T3 ES 2053429T3
- Authority
- ES
- Spain
- Prior art keywords
- buspirone
- anxiety
- phobical
- relieve
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA BUSPIRINA Y SUS SALES ACEPTABLES FARMACEUTICAMENTE SON UTILIZADAS EN LA ATENUACION DE TRANSTORNOS DE PANICO LOS CUALES PUEDEN TOMAR LA FORMA DE SINDROMES CLINICOS QUE INCLUYEN, POR EJEMPLO, ATAQUES DE PANICO, AGORAFOBIA Y ANSIEDAD FOBICA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/791,182 US4634703A (en) | 1985-10-25 | 1985-10-25 | Method for alleviation of panic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2053429T3 true ES2053429T3 (es) | 1994-08-01 |
Family
ID=25152914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES86114795T Expired - Lifetime ES2053429T3 (es) | 1985-10-25 | 1986-10-24 | El uso de buspirona para la preparacion de composiciones farmaceuticas para aliviar la ansiedad fobica. |
Country Status (11)
Country | Link |
---|---|
US (1) | US4634703A (es) |
EP (1) | EP0220696B1 (es) |
JP (1) | JPH0667841B2 (es) |
AT (1) | ATE86858T1 (es) |
AU (1) | AU592121B2 (es) |
CY (1) | CY1786A (es) |
DE (1) | DE3688038T2 (es) |
ES (1) | ES2053429T3 (es) |
GR (1) | GR3007393T3 (es) |
HK (1) | HK87094A (es) |
ZA (1) | ZA867670B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4777173A (en) * | 1987-03-25 | 1988-10-11 | Bristol-Myers Company | Method for treatment of alcohol abuse |
US4782060A (en) * | 1987-07-29 | 1988-11-01 | Bristol-Myers Company | Gepirone for alleviation of panic disorders |
SE8704097D0 (sv) * | 1987-10-22 | 1987-10-22 | Astra Ab | Oral formulation of buspirone and salts thereof |
DE3736974A1 (de) * | 1987-10-31 | 1989-05-11 | Troponwerke Gmbh & Co Kg | Verwendung von 2-pyrimidinyl-1-piperazin-derivaten |
US5468749A (en) * | 1988-08-30 | 1995-11-21 | Gawin; Frank H. | Method for treatment of substance addiction |
US6432956B1 (en) | 1990-02-12 | 2002-08-13 | William C. Dement | Method for treatment of sleep apneas |
US5166202A (en) * | 1990-09-19 | 1992-11-24 | Trustees Of The University Of Pennsylvania | Method for the treatment of panic disorder |
US5633009A (en) * | 1990-11-28 | 1997-05-27 | Sano Corporation | Transdermal administration of azapirones |
JPH04327532A (ja) * | 1991-01-31 | 1992-11-17 | Bristol Myers Squibb Co | 活動過剰を伴う注意力欠乏疾患の治療に使用する医薬製剤 |
US5431922A (en) * | 1991-03-05 | 1995-07-11 | Bristol-Myers Squibb Company | Method for administration of buspirone |
US5457100A (en) * | 1991-12-02 | 1995-10-10 | Daniel; David G. | Method for treatment of recurrent paroxysmal neuropsychiatric |
US5900250A (en) * | 1992-05-13 | 1999-05-04 | Alza Corporation | Monoglyceride/lactate ester permeation enhancer for oxybutnin |
JPH08500577A (ja) * | 1992-07-15 | 1996-01-23 | ユニヴァーシティ オブ サウス フロリダ | パニック障害の治療に関連するcckペプチドの血中濃度 |
US5631017A (en) * | 1993-03-26 | 1997-05-20 | Beth Israel Deaconess Medical Center, Inc. | Topical application of buspirone for treatment of pathological conditions associated with immune responses |
US5484788A (en) * | 1993-03-26 | 1996-01-16 | Beth Israel Hospital Association | Buspirone as a systemic immunosuppressant |
CA2167526A1 (en) * | 1993-09-29 | 1995-04-06 | Lina Tormen Taskovich | Monoglyceride/lactate ester permeation enhancer |
US5637314A (en) * | 1995-06-07 | 1997-06-10 | Beth Israel Deaconess Medical Center, Inc. | Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis |
GB9706089D0 (en) * | 1997-03-24 | 1997-05-14 | Scherer Ltd R P | Pharmaceutical composition |
US8134029B2 (en) | 2002-09-16 | 2012-03-13 | Sunovion Pharmaceuticals Inc. | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine |
US7588732B2 (en) * | 2004-03-30 | 2009-09-15 | Genesis Biosystems, Inc. | Autologus tissue harvesting and irrigation device |
WO2007006003A2 (en) | 2005-07-06 | 2007-01-11 | Sepracor Inc. | Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
DK2013835T3 (en) * | 2006-03-31 | 2015-12-14 | Sunovion Pharmaceuticals Inc | Preparation of chiral amides and AMINES |
WO2008036846A2 (en) * | 2006-09-22 | 2008-03-27 | Braincells, Inc. | Combination comprising an hmg-coa reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis |
EP2429514A1 (en) * | 2009-05-13 | 2012-03-21 | Sunovion Pharmaceuticals Inc. | Compositions comprising transnorsertraline and serotonin receptor 1a agonists/ antagonists and uses thereof |
RU2660583C1 (ru) * | 2017-08-15 | 2018-07-06 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Применение буспирона для лечения функционального головокружения |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3987052A (en) * | 1969-03-17 | 1976-10-19 | The Upjohn Company | 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines |
BE759371A (fr) * | 1969-11-24 | 1971-05-24 | Bristol Myers Co | Azaspirodecanediones heterocycliques et procedes pour leur preparation |
US3976776A (en) * | 1972-12-06 | 1976-08-24 | Mead Johnson & Company | Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones |
US4182763A (en) * | 1978-05-22 | 1980-01-08 | Mead Johnson & Company | Buspirone anti-anxiety method |
US4508726A (en) * | 1982-09-16 | 1985-04-02 | The Upjohn Company | Treatment of panic disorders with alprazolam |
US4438119A (en) * | 1982-12-23 | 1984-03-20 | Mead Johnson & Company | Method for alleviation of extrapyramidal motor disorders |
-
1985
- 1985-10-25 US US06/791,182 patent/US4634703A/en not_active Expired - Lifetime
-
1986
- 1986-10-08 ZA ZA867670A patent/ZA867670B/xx unknown
- 1986-10-21 AU AU64245/86A patent/AU592121B2/en not_active Ceased
- 1986-10-24 EP EP86114795A patent/EP0220696B1/en not_active Expired - Lifetime
- 1986-10-24 AT AT86114795T patent/ATE86858T1/de not_active IP Right Cessation
- 1986-10-24 DE DE8686114795T patent/DE3688038T2/de not_active Expired - Fee Related
- 1986-10-24 ES ES86114795T patent/ES2053429T3/es not_active Expired - Lifetime
- 1986-10-24 JP JP61253547A patent/JPH0667841B2/ja not_active Expired - Fee Related
-
1993
- 1993-03-18 GR GR920402988T patent/GR3007393T3/el unknown
-
1994
- 1994-08-25 HK HK87094A patent/HK87094A/xx not_active IP Right Cessation
-
1995
- 1995-10-20 CY CY178695A patent/CY1786A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0220696A2 (en) | 1987-05-06 |
ZA867670B (en) | 1987-06-24 |
JPS62111924A (ja) | 1987-05-22 |
JPH0667841B2 (ja) | 1994-08-31 |
EP0220696A3 (en) | 1989-10-04 |
CY1786A (en) | 1995-10-20 |
GR3007393T3 (es) | 1993-07-30 |
US4634703A (en) | 1987-01-06 |
AU6424586A (en) | 1987-04-30 |
DE3688038T2 (de) | 1993-07-01 |
ATE86858T1 (de) | 1993-04-15 |
EP0220696B1 (en) | 1993-03-17 |
DE3688038D1 (de) | 1993-04-22 |
HK87094A (en) | 1994-09-02 |
AU592121B2 (en) | 1990-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2053429T3 (es) | El uso de buspirona para la preparacion de composiciones farmaceuticas para aliviar la ansiedad fobica. | |
ES2150496T3 (es) | Cicloalquilimidazopiridinas condensadas. | |
IT1201087B (it) | Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche | |
ES2061799T3 (es) | Nuevo preparado medicamentoso y procedimiento para su preparacion. | |
ES2052603T3 (es) | Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen. | |
IT8419308A0 (it) | Procedimento per la preparazione di formulazioni galeniche particolarmente per uso farmaceutico, dietetico, cosmetico e diagnostico. | |
IT1229562B (it) | Composizioni farmaceutiche antivirali ed immunostimolanti e procedimento per la loro preparazione. | |
MX9300779A (es) | 3-(1h-tetrazol-5-y1)-4h-pyrido[1,2-a]pirimidina-4-onas composiciones farmaceuticas que las contienen y su preparacion de las mismas | |
IT8719763A0 (it) | Analoghi retro-inversi della timopentina e dei suoi frammenti, il metodo per la loro sintesi ed il loro impiego per la preparazionedi composizioni farmaceutiche. | |
ES2059312T3 (es) | Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion. | |
IT8619284A0 (it) | Composizione per la preparazione estemporanea di formulazioni per applicazioni topiche per uso farmaceutico e cosmetico. | |
IT1241079B (it) | Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico | |
IT1200944B (it) | Derivati xantinici,procedimento per la loro preparazione,composizione farmaceutiche che il contengono e loro impiego terapeutico | |
ITRM950273A0 (it) | Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni farmaceutiche. | |
DK144885D0 (da) | Substituerede 4-hydroxybenzopyraner eller farmaceutisk acceptable additionssalte deraf, deres fremstilling og anvendelse som laegemidler | |
IT8423517A0 (it) | Composizione farmaceutica per combattere infezioni virali, eprocedimento di uso per le infezioni virali. | |
ES2059442T3 (es) | Uso de gepirona para la preparacion de composiciones farmaceuticas para mitigar alteraciones de panico. | |
ITMI910846A0 (it) | Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
ITRM950589A0 (it) | Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire malattie causate dalla sovrapproduzione di dette citochine naturali, e composizioni farmaceutiche cosi' ottenibili | |
IT1214729B (it) | Derivati di acido tiofenacetico,procedimento per la loro preparazione, composizioni farmaceutiche che licontengono e loro impiego come medicamenti | |
IT8747852A0 (it) | Benzammidi sostituite, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono | |
IT8823099A0 (it) | Nuovi analoghi retro-inversi della timopentina, il metodo per la loro sintesi ed il loro impiego per la preparazione di composizioni farmaceutiche | |
ES2033927T3 (es) | Utilizacion de la forma farmaceutica de "gel" conteniendo acido n-(2,6-cicloro-m-tolil)-antranilico (acido meclofenamico) utilizable en terapia de uso topico. | |
SE8700829L (sv) | Farmaceutisk komposition | |
HN1997000048A (es) | 1,3 - oxatiolanos sustituidos con propiedades antiviricas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 220696 Country of ref document: ES |